Philadelphia-negative chronic myeloid leukemia
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
On this page
The FDA has approved this product to be used in this manner.
|Treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).|
|More Information about this product||Drug Information Portal|